Czech National Bank grew its position in Exelon Co. (NASDAQ:EXC - Free Report) by 7.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 217,868 shares of the company's stock after buying an additional 14,158 shares during the period. Czech National Bank's holdings in Exelon were worth $8,201,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Foundations Investment Advisors LLC increased its holdings in Exelon by 3.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company's stock worth $305,000 after buying an additional 255 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in shares of Exelon by 1.0% in the third quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company's stock worth $1,151,000 after acquiring an additional 274 shares during the period. Ballentine Partners LLC raised its holdings in shares of Exelon by 2.1% during the third quarter. Ballentine Partners LLC now owns 13,922 shares of the company's stock valued at $565,000 after purchasing an additional 285 shares during the last quarter. Ledyard National Bank lifted its position in Exelon by 5.1% during the third quarter. Ledyard National Bank now owns 6,348 shares of the company's stock valued at $257,000 after purchasing an additional 308 shares during the period. Finally, Allworth Financial LP lifted its position in Exelon by 1.5% during the third quarter. Allworth Financial LP now owns 20,801 shares of the company's stock valued at $843,000 after purchasing an additional 311 shares during the period. Institutional investors own 80.92% of the company's stock.
Exelon Stock Performance
Exelon stock traded up $0.10 during midday trading on Wednesday, hitting $38.02. The stock had a trading volume of 5,648,564 shares, compared to its average volume of 5,829,418. Exelon Co. has a 52-week low of $33.35 and a 52-week high of $41.19. The company has a market capitalization of $38.20 billion, a PE ratio of 15.65, a P/E/G ratio of 2.63 and a beta of 0.55. The firm's fifty day moving average is $37.96 and its two-hundred day moving average is $38.15. The company has a current ratio of 1.09, a quick ratio of 0.97 and a debt-to-equity ratio of 1.66.
Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.04. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The firm had revenue of $6.15 billion during the quarter, compared to analysts' expectations of $5.85 billion. During the same period in the prior year, the company posted $0.67 earnings per share. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. On average, research analysts forecast that Exelon Co. will post 2.45 EPS for the current year.
Exelon Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Stockholders of record on Monday, November 11th were given a $0.38 dividend. The ex-dividend date of this dividend was Friday, November 8th. This represents a $1.52 annualized dividend and a dividend yield of 4.00%. Exelon's payout ratio is 62.55%.
Analyst Ratings Changes
EXC has been the subject of a number of research reports. UBS Group boosted their target price on shares of Exelon from $40.00 to $43.00 and gave the company a "neutral" rating in a research note on Friday, September 20th. Scotiabank upped their price objective on Exelon from $40.00 to $42.00 and gave the company a "sector perform" rating in a research report on Thursday, December 12th. Morgan Stanley dropped their target price on Exelon from $46.00 to $44.00 and set an "equal weight" rating on the stock in a research report on Friday, November 22nd. Jefferies Financial Group began coverage on shares of Exelon in a research report on Thursday, September 19th. They set a "buy" rating and a $46.00 price target for the company. Finally, Barclays raised their price objective on shares of Exelon from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Six research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $42.38.
View Our Latest Research Report on Exelon
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.